Molusafe 200mg Capsule
Manufacturer
Astraea Life Sciences Pvt Ltd
Salt Composition
Molnupiravir (200mg)
Key Information
Short Description
Molusafe 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults.
Dosage Form
Capsule
Introduction
Molusafe 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use. Molusafe 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them. Before taking Molusafe 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molusafe 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Molusafe 200mg Capsule may be taken with or without food but it is better to take it at a fixed time.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is not known whether it is safe to consume alcohol with Molusafe 200mg Capsule. Please consult your doctor.
Breastfeeding Warning
Molusafe 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Molusafe 200mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Interacting Medicines
Abacavir Adefovir Didanosine Entecavir
How it works
Molusafe 200mg Capsule is an antiviral medicine. It works by inhibiting the SARS-CoV-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.
Quick Tips
Do not give Molusafe 200mg Capsule to children and adolescents aged less than 18 years. Do not stop taking Molusafe 200mg Capsule without talking to your doctor first as it will protect you from becoming severely ill from COVID-19. Even after the treatment, continue practicing COVID-appropriate behavior such as wearing a mask, social distancing, and frequent handwashing. For individuals with conceiving potential, it is advisable to use contraceptive methods while taking Molnupiravir and for 4 days after the last dose of the medicine.
Frequently asked questions
Can Molusafe 200mg Capsule be given to children?
No, Molusafe 200mg Capsule is not approved for use in children or patients under the age of 18 years as it may interfere with bone and cartilage growth.
What are the advantages of using Molusafe 200mg Capsule?
Molusafe 200mg Capsule offers better patient compliance than some alternative treatments for COVID-19. Unlike other medications that may require a healthcare professional's administration, Molusafe 200mg Capsule is an oral medication taken by mouth as prescribed by the doctor.
Are there any serious risks associated with taking Molusafe 200mg Capsule?
Yes, Molusafe 200mg Capsule poses some serious risks, including potential for birth defects in pregnant women and serious damage to bone and cartilage growth (which could cause muscle damage). Therefore, use of this medication is restricted to prescribed by a doctor and not self-medication.
Is taking Molusafe 200mg Capsule better than getting vaccinated?
No. There is no comparison between the two. Molusafe 200mg Capsule is not a substitute for vaccination and does not replace the benefits of vaccination. Vaccination is for prevention, while Molusafe 200mg Capsule helps treat an existing COVID-19 infection only when diagnosed at an early stage.
Who is at high risk of developing severe COVID-19?
People at high risk for severe COVID-19 include those aged 60 and above, those who are obese or have comorbid conditions such as high blood pressure, diabetes, asthma, respiratory diseases, or kidney disease (patients on dialysis), liver disease, and patients with weakened immunity like those with cancer.
Who should not take Molusafe 200mg Capsule?
Molusafe 200mg Capsule should not be used for prevention of COVID-19 or to treat hospitalized patients with COVID-19. Clinical trials indicate that patients hospitalized with severe COVID-19 infection have not benefited from taking Molusafe 200mg Capsule.
